Drug Delivery Strategies for the Treatment of Metabolic Diseases

被引:39
|
作者
Shi, Sanjun [1 ,2 ,3 ]
Kong, Na [1 ,2 ,3 ]
Feng, Chan [1 ,2 ,3 ]
Shajii, Aram [1 ,2 ,3 ]
Bejgrowicz, Claire [1 ,2 ,3 ]
Tao, Wei [1 ,2 ,3 ]
Forokhzad, Omid C. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Ctr Nanomed, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Anesthesiol, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
关键词
biomaterials; drug delivery; metabolic diseases; nanomedicine; LOOP INSULIN DELIVERY; ONE-POT SYNTHESIS; ORAL DELIVERY; POLYMERIC NANOPARTICLES; CONTROLLED-RELEASE; MODIFIED LEPTIN; GLUCOSE; OBESITY; INFLAMMATION; MECHANISMS;
D O I
10.1002/adhm.201801655
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Metabolic diseases occur when normal metabolic processes are disrupted in the human body, which can be congenital or acquired. The incidence of metabolic diseases worldwide has reached epidemic proportions. So far, various methods including systemic drug therapy and surgery are exploited to prevent and treat metabolic diseases. However, current pharmacotherapeutic options for treatment of these metabolic disorders remain limited and ineffective, especially reducing patient compliance to treatment. Therefore, it is desirable to exploit effective drug delivery approaches to effectively treat metabolic diseases and reduce side effects. This brief review summarizes novel delivery strategies including local, targeted, and oral drug delivery strategies, as well as intelligent stimulus-responsive drug delivery strategy, for the treatment of metabolic disorders including diabetes, obesity, and atherosclerosis.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Aquaglyceroporins: Drug Targets for Metabolic Diseases?
    Calamita, Giuseppe
    Perret, Jason
    Delporte, Christine
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [22] Hydrogel design strategies for drug delivery
    Dreiss, Cecile A.
    CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2020, 48 : 1 - 17
  • [23] Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment
    Zhang, Wenli
    Hu, Enshi
    Wang, Yajie
    Miao, Si
    Liu, Yanyan
    Hu, Yumin, III
    Liu, Ji
    Xu, Bohui
    Chen, Daquan
    Shen, Yan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 6141 - 6156
  • [24] Physical triggering strategies for drug delivery
    Sun, Tao
    Dasgupta, Anshuman
    Zhao, Zongmin
    Nurunnabi, Md
    Mitragotri, Samir
    ADVANCED DRUG DELIVERY REVIEWS, 2020, 158 : 36 - 62
  • [25] Emerging Applications of Drug Delivery Systems in Oral Infectious Diseases Prevention and Treatment
    Liang, Jingou
    Peng, Xinyu
    Zhou, Xuedong
    Zou, Jing
    Cheng, Lei
    MOLECULES, 2020, 25 (03):
  • [26] Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases
    Gonzalez, Luis F.
    Bevilacqua, Lorenzo E.
    Naves, Rodrigo
    PHARMACEUTICS, 2021, 13 (12)
  • [27] A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases
    He, Siqin
    Gui, Jiajia
    Xiong, Kun
    Chen, Meiwan
    Gao, Huile
    Fu, Yao
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [28] Drug Delivery System in the Treatment of Diabetes Mellitus
    Zhao, Ruichen
    Lu, Zhiguo
    Yang, Jun
    Zhang, Liqun
    Li, Yan
    Zhang, Xin
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [29] A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases
    Siqin He
    Jiajia Gui
    Kun Xiong
    Meiwan Chen
    Huile Gao
    Yao Fu
    Journal of Nanobiotechnology, 20
  • [30] Platelet-derived drug delivery systems: Pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond
    Zhu, Yalan
    Xu, Lingling
    Kang, Yong
    Cheng, Qinzhen
    He, Yiling
    Ji, Xiaoyuan
    BIOMATERIALS, 2024, 306